FRO:NYSEFrontline Plc Analysis
Data as of 2026-06-18 - not real-time
$38.85
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Frontline plc (FRO) is trading at $38.85, comfortably above its 20‑day SMA ($36.53) and 50‑day SMA ($36.50) while still below the 200‑day SMA ($29.05) trend line, indicating a bullish momentum that is reinforced by a MACD histogram of +0.46 and an RSI of 62, well under the overbought threshold. The stock enjoys a low beta of 0.44 and a 30‑day volatility of 36.9%, suggesting modest market sensitivity but notable price swings. Fundamentally, the company posted a remarkable 66.9% revenue growth, robust gross (55.8%) and operating (51.8%) margins, and a net profit margin of 40.2%, all of which underpin a forward‑looking DCF fair value of $51.36 – roughly a 7.5% upside from current levels. Recent news highlights a 50% dividend increase and record quarterly adjusted profit, further bolstering confidence in earnings sustainability.
Given the extreme greed sentiment (Fear & Greed Index 88.5) and a solid support at $33.80 versus resistance near $40.17, the technical setup aligns with the undervalued valuation grade, making FRO an attractive candidate for investors seeking both growth and value exposure.
Given the extreme greed sentiment (Fear & Greed Index 88.5) and a solid support at $33.80 versus resistance near $40.17, the technical setup aligns with the undervalued valuation grade, making FRO an attractive candidate for investors seeking both growth and value exposure.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators (MACD, RSI, price above short‑term SMAs)
- Strong quarterly earnings and margin expansion
- Support level provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained revenue growth of 66.9% and high profitability
- DCF valuation indicates ~7% upside
- Favorable tanker market dynamics post‑Strait of Hormuz events
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Large, modern fleet positioning for future demand cycles
- High leverage balanced by strong operating cash flow
- Industry cyclicality mitigated by diversified vessel mix
Key Metrics & Analysis
Financial Health
Revenue Growth66.90%
Profit Margin40.19%
P/E Ratio9.6
ROE35.01%
ROA9.21%
Debt/Equity92.62
P/B Ratio3.0
Op. Cash Flow$927.0M
Free Cash Flow$374.0M
Industry P/E20.4
Technical Analysis
TrendBullish
RSI62.1
Support$33.80
Resistance$40.17
MA 20$36.53
MA 50$36.50
MA 200$29.05
MACDBullish
VolumeStable
Fear & Greed Index88.5
Valuation
Fair Value$51.36
Target Price$41.75
Upside/Downside7.46%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.44
Volatility36.87%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.